Growth Metrics

Enovis (ENOV) Free Cash Flow Growth (1y) (2011 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Growth (1y) (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -1.82%
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 226.77%
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 9.73%
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn -51.69%
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -109.40%
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 133.09%
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 363.84%
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 108.16%
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 29.12%
10 Enovis 1.25 Bn 1.22 Bn 365.49 Mn 35.68%

Historic Data

Download Data 🔒
DateValue
Apr 3, 2026 35.68%
Dec 31, 2025 -8.11%
Oct 3, 2025 1,128.25%
Jul 4, 2025 110.75%
Apr 4, 2025 38.62%
Dec 31, 2024 -13.18%
Sep 27, 2024 -40.53%
Jun 28, 2024 -263.50%
Mar 29, 2024 -217.95%
Dec 31, 2023 155.64%
Sep 29, 2023 372.37%
Jun 30, 2023 82.09%
Mar 31, 2023 40.31%
Dec 31, 2022 -210.93%
Sep 30, 2022 -102.14%
Jul 1, 2022 -183.41%
Apr 1, 2022 -164.35%
Dec 31, 2021 -31.41%
Oct 1, 2021 39.82%
Jul 2, 2021 229.71%
Apr 2, 2021 138.27%
Dec 31, 2020 137.93%
Oct 2, 2020 158.14%
Jul 3, 2020 -59.02%
Apr 3, 2020 125.99%
Dec 31, 2019 -58.22%
Sep 27, 2019 -63.47%
Jun 28, 2019 90.73%
Mar 29, 2019 -602.66%
Dec 31, 2018 33.43%
Sep 28, 2018 743.23%
Jun 29, 2018 -47.55%
Mar 30, 2018 -147.93%
Dec 31, 2017 -41.66%
Sep 29, 2017 -79.05%
Jun 30, 2017 40.01%
Mar 31, 2017 22,495.28%
Dec 31, 2016 7.87%
Sep 30, 2016 -58.69%
Jul 1, 2016 -50.15%
Apr 1, 2016 100.96%
Dec 31, 2015 -27.89%
Sep 25, 2015 -52.00%
Jun 26, 2015 -17.09%
Mar 27, 2015 83.41%
Dec 31, 2014 2.63%
Sep 26, 2014 71.86%
Jun 27, 2014 -8.52%
Mar 28, 2014 -153.68%
Dec 31, 2013 10.44%
Sep 27, 2013 277.28%
Jun 28, 2013 45.11%
Mar 29, 2013 75.51%
Dec 31, 2012 1,014.97%
Sep 28, 2012 155.28%
Jun 29, 2012 175.51%
Mar 30, 2012 -7,747.73%
Dec 31, 2011 -46.34%
Sep 30, 2011 122.62%